Jianzhijia Pharmaceutical Chain Group Co., Ltd. (SHA:605266)

SHA:605266 Revenue

Jianzhijia Pharmaceutical Chain Group had revenue of 2.09B CNY in the quarter ending March 31, 2026, a decrease of -8.86%. This brings the company's revenue in the last twelve months to 8.72B, down -5.89% year-over-year. In the year 2025, Jianzhijia Pharmaceutical Chain Group had annual revenue of 8.92B, down -3.90%.

• Revenue (ttm): 8.72B
• Revenue Growth: -5.89%
• P/S Ratio: 0.31
• Revenue / Employee: 527.19K
• Employees: 16,536
• Market Cap: 2.67B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	8.92B	-361.88M	-3.90%
Dec 31, 2024	9.28B	202.15M	2.23%
Dec 31, 2023	9.08B	1.57B	20.84%
Dec 31, 2022	7.51B	2.28B	43.54%
Dec 31, 2021	5.23B	768.60M	17.21%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 30, 2026

Data Sources Report a data error